| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,448,900 | 2,323,700 | 2,442,700 | 2,675,300 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,448,900 | 2,323,700 | 2,442,700 | 2,675,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,033,900 | 2,694,400 | 1,817,600 | 2,439,400 | | Non Recurring |
-
| (590,900) |
-
|
-
| | Others | 131,800 | 132,500 | 129,300 | 127,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 283,200 | 87,700 | 495,800 | 108,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (298,800) | 298,800 | | Earnings Before Interest And Taxes | 283,200 | 87,700 | 197,000 | 407,400 | | Interest Expense | 32,600 | 35,200 | 37,200 | 40,400 | | Income Before Tax | 250,600 | 52,500 | 159,800 | 367,000 | | Income Tax Expense | 85,700 | 10,700 | 51,800 | 126,700 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 164,900 | 41,800 | 108,000 | 240,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 164,900 | 41,800 | 108,000 | 240,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $164,900 | $41,800 | $108,000 | $240,300 |
|
0.45% Nasdaq 
0.20%
Income Statement
